Franklin Biotechnology Discovery Fund Holdings history

Fund Profile

Current holdings

Data for period

31 Oct 24

(Last reporting period)

Total assets

$909.70 mm

Liabilities

$12.99 mm

Net assets

$896.71 mm

Number of holdings

91.00

Holding trends

Total assets and liabilities

Assets

Liabilities

Total number of holdings

Holdings history data

$Dollar values in millions. Negative values are Short positions. "0" is less than $100,000.

Filter holdings

All historic holdings

Current

Data to display

$Value

#Units

%Holdings

Shade data

Download data

Holding	Apr 20	Apr 20	Jul 20	Oct 20	Jan 21	Apr 21	Jul 21	Oct 21	Jan 22	Apr 22	Jul 22	Oct 22	Jan 23	Apr 23	Jul 23	Oct 23	Jan 24	Apr 24	Jul 24	Oct 24
10X Genomics, Inc.
89bio Inc COM USD 1
89bio, Inc.
Abivax SA
ACADIA Pharmaceuticals, Inc.
Acceleron Pharma, Inc.
ACELYRIN, Inc.
Achieve Life Sciences, Inc.
Acumen Pharmaceuticals, Inc.
Adagio Therapeutics, Inc.
ADMA Biologics, Inc.
Adverum Biotechnologies, Inc.
Aeglea BioTherapeutics, Inc.
Aerie Pharmaceuticals, Inc.
Akouos, Inc.
Albireo Pharma, Inc.
Alector, Inc.
Alexion Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Alpha Teknova, Inc.
Alpine Immune Sciences, Inc.
Alto Neuroscience, Inc. Alto Neuroscience, Inc.
Alto Neuroscience, Inc. Alto Neuroscience, Inc.
Alto Neuroscience, Inc. Alto Neuroscience, Inc.
Alto Neuroscience, Inc. Alto Neuroscience, Inc.
Alto Neuroscience, Inc. Alto Neuroscience, Inc., Series C
ALX Oncology Holdings, Inc.
Amgen, Inc.
Amunix Pharmaceuticals, Inc. Amunix Pharmaceuticals, Inc., Series B
Amunix Pharmaceuticals, Inc. Amunix Pharmaceuticals, Inc., Series B
Amunix Pharmaceuticals, Inc. Amunix Pharmaceuticals, Inc., Series B
Amunix Pharmaceuticals, Inc. Amunix Pharmaceuticals, Inc., Series B
Amylyx Pharmaceuticals, Inc.
AnaptysBio, Inc.
Angion Biomedica Corp.
Apellis Pharmaceuticals, Inc.
Apogee Therapeutics, Inc.
Applied Molecular Transport, Inc.
Applied Therapeutics, Inc.
Aquestive Therapeutics, Inc.
Arcus Biosciences, Inc.
Arcutis Biotherapeutics, Inc.
Argenx SE
ARS Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc., Class B
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc., Class B
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc., Class B
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc., Class B
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc., Class B
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc., Class B
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.
Arvinas Inc COM USD 0.0010
ARYA Sciences Acquisition Corp. ARYA Sciences Acquisition Corp.
ARYA Sciences Acquisition Corp. ARYA Sciences Acquisition Corp.
ARYA Sciences Acquisition Corp. III
ARYA Sciences Acquisition Corp. IV
Ascendis Pharma A/S
Assembly Biosciences, Inc.
AstraZeneca plc
Athenex, Inc.
Athira Pharma, Inc. Athira Pharma, Inc.
Athira Pharma, Inc. Athira Pharma, Inc.
Aura Biosciences, Inc.
AURINIA PHARMACEUTICALS INC ORD USD NPV
Autolus Therapeutics plc
Avantor, Inc.
Avidity Biosciences, Inc.
Beam Therapeutics Inc COM USD 0.01
BELLUS Health, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc., Series II
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Benitec Biopharma, Inc. Benitec Biopharma, Inc.
Biogen, Inc.
BioMarin Pharmaceutical, Inc.
Biomea Fusion, Inc.
BioNTech SE
Black Diamond Therapeutics, Inc.
Bluebird Bio, Inc.
Blueprint Medicines Corp.
Bolt Biotherapeutics, Inc.
Bridgebio Pharma, Inc.
CAMP4 Therapeutics Corp.
Candel Therapeutics, Inc.
Candid, Inc.
CARA THERAPEUTICS INC COM USD.001
Cardiff Oncology, Inc.
Cargo Therapeutics, Inc.
Carmot Therapeutics, Inc. Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. Carmot Therapeutics, Inc.
Carmot Therapeutics, Inc. Carmot Therapeutics, Inc., Series E
Carmot Therapeutics, Inc. Carmot Therapeutics, Inc., Series E
Catalent, Inc.
Centessa Pharmaceuticals plc
CG oncology, Inc.
Chinook Therapeutics, Inc.
CM Life Sciences III, Inc.
Codex DNA, Inc.
Codiak Biosciences, Inc.
Cogent Biosciences, Inc. Cogent Biosciences, Inc., Series B
Cogent Biosciences, Inc. Cogent Biosciences, Inc., Series B
Cogent Biosciences, Inc. Cogent Biosciences, Inc., Series B
Collegium Pharmaceutical, Inc.
Constellation Pharmaceuticals Inc COM USD 0.0001
Constellation Pharmaceuticals, Inc.
Context Therapeutics, Inc.
Contineum Therapeutics, Inc. Contineum Therapeutics, Inc., Class A
Contineum Therapeutics, Inc. Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc. Contineum Therapeutics, Inc.
Crinetics Pharmaceuticals, Inc.
CRISPR Therapeutics AG
Cullinan Therapeutics, Inc.
Cymabay Therapeutics, Inc.
Cytokinetics, Inc.
Day One Biopharmaceuticals, Inc. Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Day One Biopharmaceuticals, Inc.
DAY One Invest
Deciphera Pharmaceuticals, Inc.
DICE Therapeutics, Inc.
Disc Medicine, Inc.
Dyne Therapeutics, Inc. Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Dyne Therapeutics, Inc.
Engene Holdings, Inc. Engene Holdings, Inc.
Engene Holdings, Inc. Engene Holdings, Inc.
Engene Holdings, Inc. Engene Holdings, Inc.
Engene Holdings, Inc. Engene Holdings, Inc.
EQRx, Inc.
Equillium, Inc.
Exscientia plc
EyePoint Pharmaceuticals, Inc. EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. EyePoint Pharmaceuticals, Inc.
Fate Therapeutics, Inc.
Forte Biosciences, Inc.
FS Development Corp. FS Development Corp., Class A
FS Development Corp. FS Development Corp., Class A
FS Development Corp. II
Fusion Pharmaceuticals, Inc.
Gemini Therapeutics, Inc. Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. Gemini Therapeutics, Inc., Class A
Gilead Sciences, Inc.
Global Blood Therapeutics, Inc.
Gossamer Bio, Inc.
Guardant Health, Inc.
GW Pharmaceuticals plc
Harpoon Therapeutics, Inc.
Health Sciences Acquisitions Corp. 2
Heron Therapeutics, Inc.
Hillevax, Inc. Hillevax, Inc.
Hillevax, Inc. Hillevax, Inc.
Hillevax, Inc. Hillevax, Inc.
HilleVax, Inc. HilleVax, Inc.
HilleVax, Inc. HilleVax, Inc.
HilleVax, Inc. HilleVax, Inc.
Homology Medicines, Inc.
Horizon Therapeutics plc
IFT MONEY MARKET PORTFOLIO OEMF-SWEEP MONEY MARKET PORTFOLIO
Illumina, Inc.
Immunomedics, Inc.
Immunovant, Inc.
IN8bio, Inc.
Inhibrx, Inc.
Insmed, Inc.
Institutional Fiduciary Trust Money Market Portfolio
INTARCIA THERAPEUTICS INC COM USD NPV SER DD PHYSICAL PVT CERTIFICATES INTARCIA THERAPEUTICS INC COM USD NPV SER DD PHYSICAL PVT CERTIFICATES
INTARCIA THERAPEUTICS INC COM USD NPV SER DD PHYSICAL PVT CERTIFICATES INTARCIA THERAPEUTICS INC COM USD NPV SER DD PHYSICAL PVT CERTIFICATES
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc.
Intellia Therapeutics, Inc.
Intra-Cellular Therapies, Inc.
Ionis Pharmaceuticals, Inc.
IOVANCE BIOTHERAPEUTICS INC COM USD.001
Iovance Biotherapeutics, Inc.
iTeos Therapeutics, Inc.
IVERIC bio, Inc.
Jade Biosciences GmbH
Jasper Therapeutics, Inc. Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. Jasper Therapeutics, Inc.
Jazz Pharmaceuticals plc
Jiya Acquisition Corp.
KalVista Pharmaceuticals, Inc.
Karuna Therapeutics, Inc.
Keros Therapeutics, Inc.
Kezar Life Sciences, Inc.
Kinnate Biopharma, Inc.
Kodiak Sciences, Inc.
Korro Bio, Inc.
Kronos Bio, Inc.
Krystal Biotech, Inc.
Kura Oncology, Inc.
Kyverna Therapeutics, Inc.
Legend Biotech Corp.
LogicBio Therapeutics, Inc.
Lycia LLC Lycia LLC, Series C
Lycia LLC Lycia LLC, Series C
Lycia LLC Lycia LLC, Series C
MacroGenics, Inc.
Marinus Pharmaceuticals, Inc.
MBX Biosciences, Inc.
Menlo Therapeutics, Inc.
Merus NV
METACRINE INC PFD USD SER C METACRINE INC PFD USD SER C
METACRINE INC PFD USD SER C METACRINE INC PFD USD SER C
Metacrine, Inc. Metacrine, Inc.
Metacrine, Inc. Metacrine, Inc.
Mineralys Therapeutics, Inc.
MINERVA NEUROSCIENCES INC COM USD.0001
Mirati Therapeutics, Inc.
Mirum Pharmaceuticals, Inc.
Moderna, Inc.
MoonLake Immunotherapeutics
MORPHOSYS AG SPONSORED ADR
Nautilus Biotechnology, Inc.
Neurocrine Biosciences, Inc.
Neurogene, Inc.
Nkarta, Inc.
Novavax, Inc.
Nuvalent, Inc.
Nuvation Bio, Inc. Nuvation Bio, Inc.
Nuvation Bio, Inc. Nuvation Bio, Inc.
Ocular Therapeutix, Inc.
Odonate Therapeutics, Inc.
Olema Pharmaceuticals, Inc.
Omega Alpha SPAC
Optinose, Inc.
ORIC Pharmaceuticals, Inc.
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc.
Panacea Acquisition Corp.
Panacea Acquisition Corp. II
Pardes Biosciences, Inc.
Pfenex, Inc.
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pipeline Therapeutics, Inc. Pipeline Therapeutics, Inc., Series C
Pliant Therapeutics, Inc.
PMV Pharmaceuticals, Inc.
Point Biopharma Global, Inc.
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc.
Precision BioSciences, Inc.
Principia Biopharma, Inc.
Prometheus Biosciences, Inc.
Protara Therapeutics, Inc.
PTC Therapeutics, Inc.
RayzeBio, Inc.
Reata Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Relay Therapeutics, Inc.
Relmada Therapeutics, Inc.
Reneo Pharmaceuticals, Inc.
Repare Therapeutics, Inc.
Revance Therapeutics, Inc.
REVOLUTION Medicines, Inc.
Rocket Pharmaceuticals, Inc.
Roivant Sciences Ltd.
Royalty Pharma plc
Sage Therapeutics, Inc.
Sanofi SA Sanofi SA, Escrow Account
Sanofi SA Sanofi SA, Escrow Account
Sanofi SA Sanofi SA, Escrow Account
Sanofi SA Sanofi SA, Escrow Account
Sanofi SA Sanofi SA, Escrow Account
Sanofi-Aventis de Colombia SA Sanofi SA, Escrow Account
Sanofi-Aventis de Colombia SA Sanofi SA, Escrow Account
Sanofi-Aventis de Colombia SA Sanofi SA, Escrow Account
Sanofi-Aventis de Colombia SA Sanofi SA
Sanofi-Aventis de Colombia SA Sanofi SA
Sanofi-Aventis de Colombia SA Sanofi-Aventis de Colombia SA
Sarepta Therapeutics, Inc.
Sartorius AG
Sartorius Stedim Biotech
Scholar Rock Holding Corp.
Seagen, Inc.
Shattuck Labs, Inc.
Singular Genomics Systems, Inc.
Soaring Eagle Acquisition Corp.
Social Capital Suvretta Holdings Corp. I
Social Capital Suvretta Holdings Corp. II
Social Capital Suvretta Holdings Corp. III
Social Capital Suvretta Holdings Corp. IV
SpringWorks Therapeutics Inc COM USD 1
Spyre Therapeutics, Inc.
Structure Therapeutics, Inc. Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Structure Therapeutics, Inc.
Sutro Biopharma, Inc.
Syndax Pharmaceuticals, Inc.
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. Taysha Gene Therapies, Inc.
Terns Pharmaceuticals, Inc.
Therapeutics Acquisition Corp.
Thermo Fisher Scientific, Inc.
Travere Therapeutics, Inc.
Trevi Therapeutics Inc COM USD 1
Trillium Therapeutics, Inc.
TRUE NORTH THERAPEUTICS INC ESCROW ACCOUNT REF SM#647457 TRUE NORTH THERAPEUTICS INC ESCROW ACCOUNT REF SM#647457
TRUE NORTH THERAPEUTICS INC ESCROW ACCOUNT REF SM#647457 TRUE NORTH THERAPEUTICS INC ESCROW ACCOUNT REF SM#647457
True North Therapeutics Inc.,Escrow Account True North Therapeutics Inc.,Escrow Account
True North Therapeutics Inc.,Escrow Account True North Therapeutics Inc.,Escrow Account
Ultragenyx Pharmaceutical, Inc.
uniQure NV
uniQure NV ORD USD.05
United Medicines Biopharma Ltd. United Medicines Biopharma Ltd., Series A
United Medicines Biopharma Ltd. United Medicines Biopharma Ltd., Series A
Vaxcyte, Inc.
Vertex Pharmaceuticals, Inc.
Viela Bio Inc COM USD 1
Viela Bio, Inc.
Viridian Therapeutics, Inc.
Vistagen Therapeutics, Inc.
VistaGen Therapeutics, Inc.
VYNE Therapeutics, Inc. VYNE Therapeutics, Inc.
VYNE Therapeutics, Inc. VYNE Therapeutics, Inc.
Xenon Pharmaceuticals, Inc.
Yumanity Therapeutics, Inc.
Yumanity, Inc.
Zealand Pharma A/S
Zentalis Pharmaceuticals, Inc.
Zogenix, Inc.
Zymeworks, Inc.